论文部分内容阅读
Background Acute fatty liver of pregnancy (AFLP) can lead to fatal liver damage that occurs in the third trimester or early postpartum period.The effect of traditional therapy is not very ideal for facilitating hepatic recovery.The safety and effect of Lis non-bioartificial liver (Li-NBAL) in application for treating AFLP are lacking systematic introduction.